Literature DB >> 11146162

Chronic myelogenous leukemia primitive hematopoietic progenitors demonstrate increased sensitivity to growth factor-induced proliferation and maturation.

R Bhatia1, H A Munthe, A D Williams, F Zhang, S J Forman, M L Slovak.   

Abstract

We investigated whether primary chronic myelogenous leukemia (CML) hematopoietic progenitors demonstrated altered proliferation and maturation in response to growth factor (GF) stimulation. The effect of GF stimulation on proliferation and expansion of committed and primitive progenitors (colony forming cells [CFC]) was evaluated. Culture of CML and normal CD34(+) cells with different GF for 7 days resulted in similar expansion of committed progenitors (CFC). In contrast, GF culture conditions that expanded normal primitive progenitors (week-6 long-term culture-initiating cells (LTC-IC)] led to depletion of CML LTC-IC numbers. GF culture also resulted in increased depletion of week-10 extended LTC-IC, which represent an even more primitive progenitor population, from CML compared with normal CD34(+) cells. CML CD34(+) cells enter into cycle more quickly than normal CD34(+) cells and CML CFC expansion was accelerated compared to normal CFC. Evaluation of primitive progenitor proliferation using PKH-26 and single-cell LTC-IC analysis demonstrated that the majority of CML LTC-IC remaining after GF culture originated from divided CD34(+) cells, whereas GF-cultured normal LTC-IC were derived mainly from undivided cells. Depletion of CML primitive progenitor numbers in association with increased proliferation suggests increased sensitivity to GF-induced maturation. These studies indicate that CML primitive progenitors have enhanced sensitivity to GF-induced cell division and maturation. Altered GF responsiveness may contribute to abnormal expansion of malignant myeloid cells in CML. These findings may also be applied toward the development of novel approaches to select benign stem cells in CML.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11146162     DOI: 10.1016/s0301-472x(00)00545-2

Source DB:  PubMed          Journal:  Exp Hematol        ISSN: 0301-472X            Impact factor:   3.084


  8 in total

1.  The prolonged life-span of alveolar macrophages.

Authors:  Jaime Murphy; Ross Summer; Andrew A Wilson; Darrell N Kotton; Alan Fine
Journal:  Am J Respir Cell Mol Biol       Date:  2008-01-10       Impact factor: 6.914

2.  Chronic myelogenous leukemia stem and progenitor cells demonstrate chromosomal instability related to repeated breakage-fusion-bridge cycles mediated by increased nonhomologous end joining.

Authors:  Sujata Chakraborty; Jeremy M Stark; Can-Lan Sun; Hardik Modi; WenYong Chen; Timothy R O'Connor; Stephen J Forman; Smita Bhatia; Ravi Bhatia
Journal:  Blood       Date:  2012-04-04       Impact factor: 22.113

3.  Role of BCR-ABL-Y177-mediated p27kip1 phosphorylation and cytoplasmic localization in enhanced proliferation of chronic myeloid leukemia progenitors.

Authors:  S Chu; T McDonald; R Bhatia
Journal:  Leukemia       Date:  2010-03-04       Impact factor: 11.528

4.  Effects of dasatinib on SRC kinase activity and downstream intracellular signaling in primitive chronic myelogenous leukemia hematopoietic cells.

Authors:  Heiko Konig; Mhairi Copland; Su Chu; Richard Jove; Tessa L Holyoake; Ravi Bhatia
Journal:  Cancer Res       Date:  2008-12-01       Impact factor: 12.701

5.  Effective and selective inhibition of chronic myeloid leukemia primitive hematopoietic progenitors by the dual Src/Abl kinase inhibitor SKI-606.

Authors:  Heiko Konig; Tessa L Holyoake; Ravi Bhatia
Journal:  Blood       Date:  2007-12-04       Impact factor: 22.113

Review 6.  Expression of CD25 on leukemic stem cells in BCR-ABL1+ CML: Potential diagnostic value and functional implications.

Authors:  Irina Sadovnik; Harald Herrmann; Gregor Eisenwort; Katharina Blatt; Gregor Hoermann; Niklas Mueller; Wolfgang R Sperr; Peter Valent
Journal:  Exp Hematol       Date:  2017-04-27       Impact factor: 3.084

7.  Gene Expression Differences between Enriched Normal and Chronic Myelogenous Leukemia Quiescent Stem/Progenitor Cells and Correlations with Biological Abnormalities.

Authors:  M Affer; S Dao; C Liu; A B Olshen; Q Mo; A Viale; C L Lambek; T G Marr; B D Clarkson
Journal:  J Oncol       Date:  2011-02-23       Impact factor: 4.375

8.  A high-content cytokine screen identifies myostatin propeptide as a positive regulator of primitive chronic myeloid leukemia cells.

Authors:  Sofia von Palffy; Niklas Landberg; Carl Sandén; Dimitra Zacharaki; Mansi Shah; Naoto Nakamichi; Nils Hansen; Maria Askmyr; Henrik Lilljebjörn; Marianne Rissler; Christine Karlsson; Stefan Scheding; Johan Richter; Connie J Eaves; Ravi Bhatia; Marcus Järås; Thoas Fioretos
Journal:  Haematologica       Date:  2019-10-03       Impact factor: 9.941

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.